Skip to content

Short Life Agents in Balanced Anesthesia on Obstructive Sleep Apnea Syndrome

Respiratory Impact of Short Life Agents Used in Balanced Anesthesia on Patients Suffering or Suspected of Obstructive Sleep Apnea (OSA) Syndrome

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02717780
Acronym
DESAT
Enrollment
60
Registered
2016-03-24
Start date
2016-02-29
Completion date
2018-06-30
Last updated
2018-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Apnea, Obstructive, Sleep Apnea Syndromes

Brief summary

The investigators aim to assess the respiratory effect of short half-life agents in balanced anesthesia on patients suffering from non-treated or suspected obstructive sleep apnea syndrome (OSA) We will study the impact on OSA of a regimen of remifentanil-desflurane versus a regimen of fentanyl-sevoflurane. Each patient will undergo three respiratory portable polygraphies: the night before the surgery ; the first night following the surgery ; the third night following the surgery.

Interventions

DRUGFentanyl and sevoflurane

Sponsors

Centre Hospitalier Universitaire Vaudois
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Physical status I - III * Patient scheduled to undergo lower limb orthopedic surgery * Patients known for non-treated obstructive sleep apnea or suspected of having an obstructive sleep apnea

Exclusion criteria

* Patients known for treated obstructive sleep apnea ; * Severe respiratory disease (i.e., chronic obstructive pulmonary disease, asthma, pulmonary fibrosis); * Severe cardiovascular disease * Chronic use of opiates ≥ 30mg/j morphine eq. * Chronic use of benzodiazepine * Inability to consent * Refusal

Design outcomes

Primary

MeasureTime frame
Number of apnea and hypopnea events per hour of sleep (Apnea-Hypopnea index) in supine positionpostoperative night 1

Secondary

MeasureTime frame
Percentage of time with saturation < 90%postoperative night 1 and night 3
Mean oxygen saturationpostoperative night 1 and night 3
Total sleep durationpostoperative night 1 and night 3
Percentage of time in supine positionpostoperative night 1 and night 3
Number of apnea and hypopnea events per hour of sleep (Apnea-Hypopnea index) in supine positionpostoperative night 1 and night 3
Mean amplitude of desaturation (AD%)postoperative night 1 and night 3
Percentage of time in obstructive apneapostoperative night 1 and night 3
Percentage of time in central apneapostoperative night 1 and night 3
Percentage of time in mixt apneapostoperative night 1 and night 3
Number of obstructive apnea eventspostoperative night 1 and night 3
Sleep Apnea screening questionnaire (Berlin questionnaire)24h before surgery
Sleep Apnea screening questionnaire (Epworth questionnaire)24h before surgery
Sleep Apnea screening questionnaire (NOSAS questionnaire)24h before surgery
Pain scores (numeric rating scale, 0-10)postoperative day 0,1,2 and 3
Postoperative nausea and vomiting (yes/no)postoperative day 0,1,2 and 3
Pruritus (yes/no)postoperative day 0,1,2 and 3
Opiate consumption (mg morphine)postoperative day 0,1,2 and 3
Level of satisfaction (visual analog scale)postoperative day 3
Sleep Apnea screening questionnaire (STOP BANG questionnaire)24h before surgery

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026